160 related articles for article (PubMed ID: 16271750)
1. Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Brewer CA; Blessing JA; Nagourney RA; McMeekin DS; Lele S; Zweizig SL
Gynecol Oncol; 2006 Feb; 100(2):385-8. PubMed ID: 16271750
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Burnett AF; Roman LD; Garcia AA; Muderspach LI; Brader KR; Morrow CP
Gynecol Oncol; 2000 Jan; 76(1):63-6. PubMed ID: 10620443
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.
Schilder RJ; Blessing JA; Morgan M; Mangan CE; Rader JS
Gynecol Oncol; 2000 Feb; 76(2):204-7. PubMed ID: 10637071
[TBL] [Abstract][Full Text] [Related]
4. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L
Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and gemcitabine in patients with metastatic cervical cancer.
Lorvidhaya V; Kamnerdsupaphon P; Chitapanarux I; Sukthomya V; Tonusin A
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1057-62. PubMed ID: 15272585
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2.
Termrungruanglert W; Tresukosol D; Vasuratna A; Sittisomwong T; Lertkhachonsuk R; Sirisabya N
Gynecol Oncol; 2005 May; 97(2):576-81. PubMed ID: 15863162
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.
Brewer CA; Blessing JA; Nagourney RA; Morgan M; Hanjani P
Gynecol Oncol; 2006 Nov; 103(2):446-50. PubMed ID: 16643994
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.
Hasturk S; Hatabay N; Ece F; Karatasli M; Hanta I
Am J Clin Oncol; 2009 Jun; 32(3):280-5. PubMed ID: 19433960
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.
Nagourney RA; Brewer CA; Radecki S; Kidder WA; Sommers BL; Evans SS; Minor DR; DiSaia PJ
Gynecol Oncol; 2003 Jan; 88(1):35-9. PubMed ID: 12504624
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
Schilder RJ; Blessing J; Cohn DE
Gynecol Oncol; 2005 Jan; 96(1):103-7. PubMed ID: 15589587
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
Matulonis UA; Campos S; Duska L; Krasner CN; Atkinson T; Penson RT; Seiden MV; Verrill C; Fuller AF; Goodman A;
Gynecol Oncol; 2006 Oct; 103(1):160-4. PubMed ID: 16566993
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Mannel RS; Blessing JA; Boike G
Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
[TBL] [Abstract][Full Text] [Related]
17. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix.
Pohlmann P; DiLeone LP; Cancella AI; Caldas AP; Dal Lago L; Campos O; Monego E; Rivoire W; Schwartsmann G
Am J Clin Oncol; 2002 Oct; 25(5):496-501. PubMed ID: 12393992
[TBL] [Abstract][Full Text] [Related]
19. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Moore DH; Blessing JA; McQuellon RP; Thaler HT; Cella D; Benda J; Miller DS; Olt G; King S; Boggess JF; Rocereto TF
J Clin Oncol; 2004 Aug; 22(15):3113-9. PubMed ID: 15284262
[TBL] [Abstract][Full Text] [Related]
20. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
